Información del artículo
El hiperparatiroidismo primario (HPTP) es una enfermedad endocrina de presentación frecuente. Se debe sospechar HPTP en pacientes con hipercalcemia en ocasiones leve en ausencia de otras causas. Es la causa más frecuente de hipercalcemia en pacientes ambulatorios, y se descubre de forma casual en análisis habituales. En la actualidad la mayoría de los pacientes están asintomáticos. El tratamiento quirúrgico es el único tratamiento efectivo de forma permanente para los pacientes con HPTP, con un elevado porcentaje de éxitos (95%) y escasas complicaciones perioperatorias (5%). Las técnicas de localización no son necesarias para el diagnóstico de HPTP. El papel de las técnicas de localización en la primera cirugía no está claro, ya que la exploración bilateral del cuello por un cirujano experto consigue un alto índice de curación. La localización preoperatoria del adenoma por ecografía o gammagrafía con sestamibi permite realizar cirugía mínimamente invasiva. Es obligatorio realizar técnicas de localización en pacientes con HPTP persistente o recurrente tras la primera cirugía.
Palabras clave:
Hiperparatiroidismo
Ecografía
Gammagrafía con sestamibi
Primary hyperparathyroidism (PHPT) is a common endocrine disease. The presence of PHPT should be suspected in patients with persistent, often mild, hypercalcemia in the absence of any other apparent etiology. Hyperparathyroidism is the most frequent cause of hypercalcemia in the outpatient setting and is usually discovered incidentally by routine laboratory testing. Currently, most patients are asymptomatic. The only permanently effective therapy for patients with PHPT is surgery, with a high cure rate (95%) and few perioperative complications (5%). Parathyroid imaging is not required in the diagnosis of PHPT. The role of preoperative localization in patients undergoing initial neck exploration is unclear, since a bilateral approach in the hands of experienced surgeons achieves a high cure rate. Preoperative localization of adenomas with ultrasonography or sestamibi scanning allows a minimally invasive approach to be used. Localization studies are required when PHPT persists or recurs after surgery.
Key words:
Hyperparathyroidism
Ultrasonography
Sestamibi scan
El Texto completo está disponible en PDF
Bibliografía
[1.]
E. Lundgren, J. Rastad, E. Thrufjell, G. Akerstrom, S. Ljunghall.
Population- based screening for primary hyperparathyroidism with serum calcium and parathyroid hormone values in menopausal women.
Surgery, 121 (1997), pp. 287-294
[2.]
The American Association of Clinical Endocrinologists and the American Association of Endocrine Surgeons Position Statement on the Diagnosis and Management of Primary Hyperparathyroidism. Endocr Pract. 2005; 11:49-54.
[3.]
M. Muñoz-Torres, F. Escobar-Jiménez, J. Díaz Pérez De Madrid.
Retos al diagnóstico hospitalario del hiperparatiroidismo primario.
Med Clin (Barc), 93 (1989), pp. 209-210
[4.]
J.P. Bilezikian, S.J. Silverberg.
Clinical practice. Asymptomatic primary hyperparathyroidism.
N Engl J Med, 350 (2004), pp. 1746-1751
[5.]
S.J. Silverberg, E. Shane, T.P. Jacobs, E. Siris, J.P. Bilezikian.
A 10- year prospective study of primary hyperparathyroidism with or without parathyroid surgery.
N Engl J Med, 341 (1999), pp. 1249-1255
[6.]
M. Muñoz Torres, M. Ventosa Viñas, P. Mezquita Raya, V. Luna, F. López Rodríguez, D. Becerra, et al.
Utilidad de la densitometría ósea en la evaluación del hiperparatiroidismo primario.
Med Clin (Barc), 114 (2000), pp. 521-524
[7.]
S.J. Silverberg, J.P. Bilezikian, H.G. Bone, G.B. Talpos, M.J. Horwitz, A.F. Stewart.
Therapeutic controversies in primary hyperparathyroidism.
J Clin Endocrinol Metab, 84 (1999), pp. 2275-2285
[8.]
J.T. Potts Jr.
Proceedings of the NIH Consensus Development Conference on Diagnosis and Management of Asymptomatic Primary Hyperparathyroidism.
J Bone Miner Res, 6 (1991), pp. S9-S13
[9.]
J.P. Bilezikian, J.T. Potts Jr, G-H. Fuleihan, M. Kleerekoper, R. Neer, M. Peacock, et al.
Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century.
J Bone Miner Res, 17 (2002), pp. N2-N11
[10.]
R.A. Kaplan, W.H. Snyder, A. Stewart, C.Y. Pak.
Metabolic effects of parathyroidectomy in asymptomatic primary hyperparathyroidism.
J Clin Endocrinol Metab, 42 (1976), pp. 415-426
[11.]
A.K. Chan, Q.Y. Duh, M.H. Katz, A.E. Siperstein, O.H. Clark.
Clinical manifestations of primary hyperparathyroidism before and after parathyroidectomy. A case-control study.
Ann Surg, 222 (1995), pp. 402-412
[12.]
T. Stefenelli, C. Abela, H. Frank, J. Koller-Strametz, S. Globits, J. Bergler-Klein, et al.
Cardiac abnormalities in patients with primary hyperparathyroidism: implications for follow-up.
J Clin Endocrinol Metab, 82 (1997), pp. 106-112
[13.]
S.J. Silverberg, F.G. Locker, J.P. Bilezikian.
Vertebral osteopenia: a new indication for surgery in primary hyperparathyroidism.
J Clin Endocrinol Metab, 81 (1996), pp. 4007-4012
[14.]
R. Nomura, T. Sugimoto, T. Tsukamoto, M. Yamauchi, H. Sowa, Q. Chen, et al.
Marked and sustained increase in bone mineral density after parathyroidectomy in patients with primary hyperparathyroidism; a six-year longitudinal study with or without parathyroidectomy in a Japanese population.
Clin Endocrinol (Oxf), 60 (2004), pp. 335-342
[15.]
J.A. Sosa, N.R. Powe, M.A. Levine, R. Udelsman, M.A. Zeiger.
Profile of a clinical practice: thresholds for surgery and surgical outcomes for patients with primary hyperparathyroidism: a national survey of endocrine surgeons.
J Clin Endocrinol Metab, 83 (1998), pp. 2658-2665
[16.]
S.R. Schell, N.E. Dudley.
Clinical outcomes and fiscal consequences of bilateral neck exploration for primary idiopathic hyperparathyroidism without preoperative radionuclide imaging or minimally invasive techniques.
Surgery, 133 (2003), pp. 32-39
[17.]
I.L. Nilsson, L. Yin, E. Lundgren, J. Rastad, A. Ekbom.
Clinical presentation of primary hyperparathyroidism in Europe –nationwide cohort analysis on mortality from nonmalignant causes.
J Bone Miner Res, 17 (2002), pp. N68-N74
[18.]
M. Yao, C. Jamieson, R. Blend.
Magnetic resonance imaging in preoperative localization of diseased parathyroid glands: a comparison with isotope scanning and ultrasonography.
Can J Surg, 36 (1993), pp. 241-244
[19.]
M.S. Weinberger, K.T. Robbins.
Diagnostic localization studies for primary hyperparathyroidism. A suggested algorithm.
Arch Otolaryngol Head Neck Surg, 120 (1994), pp. 1187-1189
[20.]
B.K. Mitchell, B.K. Kinder, E. Cornelius, A.F. Steward.
How should patients with primary Hyperparathyroidism be treated?.
J Clin Endocrinol Metab, 88 (2003), pp. 3011-3014
[21.]
M. Ishibashi, H. Nishida, Y. Hiromatsu, K. Kojima, E. Tabuchi, N. Hayabuchi.
Comparison of technetium-99m-MIBI, technetium- 99m-tetrofosmin, ultrasound and MRI for localization of abnormal parathyroid glands.
J Nucl Med, 39 (1998), pp. 320-324
[22.]
H. Takami, S. Satake, K. Nakamura, A. Kubo.
What are the indications for 99mTc-sestamibi scintigraphy in hyperparathyroidism?.
Clin Endocrinol (Oxf), 45 (1996), pp. 121
[23.]
P. Thule, K. Thakore, J. Vansant, W. McGarity, C. Weber, L.S. Phillips.
Preoperative localization of parathyroid tissue with technetium-99m sestamibi 123I subtraction scanning.
J Clin Endocrinol Metab, 78 (1994), pp. 77-82
[24.]
D.J. Halvorson, G.J. Burke, A.R. Mansberger Jr, J.P. Wei.
Use of technetium Tc99m sestamibi and iodine 123 radionuclide scan for preoperative localization of abnormal parathyroid glands in primary hyperparathyroidism.
South Med J, 87 (1994), pp. 336-339
[25.]
E. Hindie, D. Melliere, L. Perlemuter, C. Jeanguillaume, P. Galle.
Primary hyperparathyroidism: higher success rate of first surgery after preoperative Tc-99sestamibi-I-123 subtraction scanning.
Radiology, 204 (1997), pp. 221-228
[26.]
A.C. Civelek, E. Ozalp, P. Donovan, R. Udelsman.
Prospective evaluation of delayed technetium-99m sestamibi SPECT scintigraphy for preoperative localization of primary hyperparathyroidism.
Surgery, 131 (2002), pp. 149-157
[27.]
S.M. Roe, P.W. Brown, L.M. Pate, J.B. Summitt, D.L. Ciraulo, R.P. Burns.
Initial cervical exploration for parathyroidectomy is not benefited by preoperative localization studies.
Am Surg, 64 (1998), pp. 503-507
[28.]
E.D. Dillavou, J.S. Jenoff, C.M. Intenzo, H.E. Cohn.
The utility of sestamibi scanning in the operative management of patients with primary hyperparathyroidism.
J Am Coll Surg, 190 (2000), pp. 540-545
[29.]
J. Allendorf, L. Kim, J. Chabot, M. DiGiorgi, K. Spanknebel, P. Lo- Gerfo.
The impact of sestamibi scanning on the outcome of parathyroid surgery.
J Clin Endocrinol Metab, 88 (2003), pp. 3015-3018
[30.]
N. Jaskowiak, J.A. Norton, H.R. Alexander, J.L. Doppman, T. Shawker, M. Skarulis, et al.
A prospective trial evaluating a standard approach to reoperation for missed parathyroid adenoma.
Ann Surg, 224 (1996), pp. 308-320
[31.]
W. Shen, M. Duren, E. Morita, C. Higgins, Q.Y. Duh, A.E. Siperstein, et al.
Reoperation for persistent or recurrent primary hyperparathyroidism.
Arch Surg, 131 (1996), pp. 861-867
[32.]
H.R. Alexander Jr, C.C. Chen, T. Shawker, P. Choyke, T.J. Chan, R. Chang, et al.
Role of preoperative localization and intraoperative localization maneuvers including intraoperative PTH assay determination for patients with persistent or recurrent hyperparathyroidism.
J Bone Miner Res, 17 (2002), pp. N133-N140
[33.]
K.E. Levin, G.A. Gooding, M. Okerlund, C.B. Higgins, D. Norman, T.H. Newton, et al.
Localizing studies in patients with persistent or recurrent hyperparathyroidism.
Surgery, 102 (1987), pp. 917-925
[34.]
J.A. Pallotta, B.A. Sacks, D.E. Moller, H. Eisenberg.
Arteriographic ablation of cervical parathyroid adenomas.
J Clin Endocrinol Metab, 69 (1989), pp. 1249-1255
[35.]
M.P. MacFarlane, D.L. Fraker, H. Shawker, J.A. Norton, J.L. Doppman, R.A. Chang, et al.
Use of preoperative fine-needle aspiration in patients undergoing reoperation for primary hyperparathyroidism.
Surgery, 116 (1994), pp. 959-964
[36.]
D.L. Miller, J.L. Doppman, A.G. Krudy, T.H. Shawker, J.A. Norton, J.J. Vucich, et al.
Localization of parathyroid adenomas in patients who have undergone surgery. Part II. Invasive procedures.
Radiology, 162 (1987), pp. 138-141
[37.]
J. Norman, H. Chheda, C. Farrell.
Minimally invasive parathyroidectomy for primary hyperparathyroidism: decreasing operative time and potential complications while improving cosmetic results.
Am Surg, 64 (1998), pp. 391-395
[38.]
N.D. Perrier, P. Ituarte, E. Morita, T. Hamil, R. Gielow, Q.Y. Duh, et al.
Parathyroid surgery: Separating promise for reality.
J Clin Endocrinol Metab, 87 (2002), pp. 1024-1029
[39.]
G.L. Irvin III, A.S. Molinari, A.C. Figueroa, D.M. Carneiro.
Improve success rate in reoperative parathyroidectomy with intraoperative PTH assay.
Am Surg, 229 (1999), pp. 874-878
[40.]
P.C. Gauger, G. Agarwal, B.G. England, L.W. Delbridge, K.A. Matz, M. Wilkinson, et al.
Intraoperative parathyroid hormone monitoring fails to detect double parathyroid adenomas: a 2 institution experience.
Surgery, 130 (2001), pp. 1005-1010
Copyright © 2006. Sociedad Española de Endocrinología y Nutrición
